| Literature DB >> 14741739 |
S Theoleyre1, Y Wittrant, S Couillaud, P Vusio, M Berreur, C Dunstan, F Blanchard, F Rédini, D Heymann.
Abstract
Osteoprotegerin (OPG) is a decoy receptor for receptor activator of nuclear factor kappaB ligand (RANKL), an inducer of osteoclastogenesis via its receptor RANK. We recently demonstrated that OPG also exerts a direct effect in osteoclasts by regulating protease expression. Herein, we showed that OPG-induced pro-matrix metalloproteinase-9 activity was abolished by ras/MAPK inhibitors in purified osteoclasts. OPG induced the phosphorylation of p38 and ERK1/2 in RAW264.7 cells. Only p38 activation was totally abolished by a blocking anti-RANKL antibody or an excess of RANKL. Surface plasmon resonance experiments revealed that RANK, RANKL and OPG are able to form a tertiary complex. These results suggested a potential formation of a tertiary complex RANK-RANKL-OPG on osteoclasts. Thus, OPG is not only a soluble decoy receptor for RANKL but must be also considered as a direct effector of osteoclast functions.Entities:
Mesh:
Substances:
Year: 2004 PMID: 14741739 DOI: 10.1016/j.bbamcr.2003.10.005
Source DB: PubMed Journal: Biochim Biophys Acta ISSN: 0006-3002